Stay updated with breaking news from Nasdaq Cyth. Get real-time updates on events, politics, business, and more. Visit us for reliable news and exclusive interviews.
Cyclo Therapeutics, Inc. (NASDAQ:CYTH – Get Free Report) was the target of a significant increase in short interest during the month of December. As of December 31st, there was short interest totalling 331,200 shares, an increase of 83.3% from the December 15th total of 180,700 shares. Currently, 3.1% of the company’s stock are short sold. […]
Cyclo Therapeutics, Inc. (NASDAQ:CYTH – Get Free Report) saw a large increase in short interest in November. As of November 15th, there was short interest totalling 223,000 shares, an increase of 76.4% from the October 31st total of 126,400 shares. Currently, 2.6% of the company’s shares are sold short. Based on an average daily trading […]
Cyclo Therapeutics, Inc. (NASDAQ:CYTH – Get Free Report) was the target of a large decrease in short interest in September. As of September 15th, there was short interest totalling 133,100 shares, a decrease of 31.3% from the August 31st total of 193,800 shares. Based on an average daily volume of 56,400 shares, the short-interest ratio […]
Cyclo Therapeutics (NASDAQ:CYTH – Get Free Report) and Axcella Health (NASDAQ:AXLA – Get Free Report) are both small-cap medical companies, but which is the better investment? We will compare the two businesses based on the strength of their institutional ownership, analyst recommendations, dividends, profitability, risk, earnings and valuation. Earnings & Valuation This table compares Cyclo […]
Cyclo Therapeutics, Inc. (NASDAQ:CYTH – Get Free Report) was the target of a large increase in short interest in the month of July. As of July 15th, there was short interest totalling 94,400 shares, an increase of 93.8% from the June 30th total of 48,700 shares. Based on an average daily trading volume, of 153,200 […]